Advertisement
Review Article| Volume 50, ISSUE 2, P181-189, May 2023

Evolution in the Pathologic Classification of Renal Neoplasia

Published:February 20, 2023DOI:https://doi.org/10.1016/j.ucl.2023.01.001

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Urologic Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Hansel D.E.
        • Kane C.J.
        • Paner G.P.
        • et al.
        The kidney: a comprehensive guide to pathologic diagnosis and management. Springer, New York, NY2016
        • Delahunt B.
        • Eble J.N.
        History of the development of the classification of renal cell neoplasia.
        Clin Lab Med. 2005; 25: 231-246
        • Young R.H.
        • Eble J.N.
        The history of urologic pathology: an overview.
        Histopathology. 2019; 74: 184-212
        • Mancilla-Jimenez R.
        • Stanley R.J.
        • Blath R.A.
        Papillary renal cell carcinoma: a clinical, radiologic, and pathologic study of 34 cases.
        Cancer. 1976; 38: 2469-2480
      1. Mostofi FK, Sesterhenn IA, and Sobin LH. Histological typing of kidney tumours, 1981, World Health Organization; Geneva, Switzerland.

        • Thoenes W.
        • Storkel S.
        • Rumpelt H.J.
        Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics.
        Pathol Res Pract. 1986; 181: 125-143
        • Szucs S.
        • Muller-Brechlin R.
        • DeRiese W.
        • et al.
        Deletion 3p: the only chromosome loss in a primary renal cell carcinoma.
        Cancer Genet Cytogenet. 1987; 26: 369-373
        • Kovacs G.
        • Wilkens L.
        • Papp T.
        • et al.
        Differentiation between papillary and nonpapillary renal cell carcinomas by DNA analysis.
        J Natl Cancer Inst. 1989; 81: 527-530
        • Kovacs A.
        • Kovacs G.
        Low chromosome number in chromophobe renal cell carcinomas.
        Genes Chromosomes Cancer. 1992; 4: 267-268
        • Storkel S.
        • Eble J.N.
        • Adlakha K.
        • et al.
        Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC).
        Cancer. 1997; 80: 987-989
        • Kovacs G.
        • Akhtar M.
        • Beckwith B.J.
        • et al.
        The Heidelberg classification of renal cell tumours.
        J Pathol. 1997; 183: 131-133
        • Mostofi F.K.
        • Davis C.J.
        • Sobin L.H.
        Histological typing of kidney tumors.
        2nd edition. Springer; Geneva, Switzerland, 1998
        • Eble J.N.
        • Sauter G.
        • Epstein J.I.
        • et al.
        World Health Organization classification of tumours. Pathology and genetics of tumours of the urinary system and male genital organs.
        IARC; Lyon, France, 2004
        • Moch H.
        • Humphrey P.A.
        • Ulbright T.M.
        • et al.
        4th edition. WHO classification of tumours of the urinary system and male genital organs. 8. IARC, Lyon, France2016
        • Board WcoTE
        Urinary and male genital tumours (WHO classification of tumours). IARC, Lyon, France2022
        • Moch H.
        • Amin M.B.
        • Berney D.M.
        • et al.
        The 2022 World Health Organization Classification of tumours of the urinary system and male genital organs-part a: renal, penile, and testicular tumours.
        Eur Urol. 2022; 82: 458-468
        • Ricketts C.J.
        • Linehan W.M.
        • Spellman P.T.
        • et al.
        • Cancer Genome Atlas Research Network
        Comprehensive molecular characterization of papillary renal-cell carcinoma.
        N Engl J Med. 2016; 374: 135-145
        • Chan E.
        • Stohr B.A.
        • Butler R.S.
        • et al.
        Papillary renal cell carcinoma with microcystic architecture is strongly associated with extrarenal invasion and metastatic disease.
        Am J Surg Pathol. 2022; 46: 392-403
        • Palsgrove D.N.
        • Li Y.
        • Pratilas C.A.
        • et al.
        Eosinophilic Solid and Cystic (ESC) renal cell carcinomas harbor tsc mutations: molecular analysis supports an expanding clinicopathologic spectrum.
        Am J Surg Pathol. 2018; 42: 1166-1181
        • Falzarano S.M.
        • McKenney J.K.
        • Montironi R.
        • et al.
        Renal cell carcinoma occurring in patients with prior neuroblastoma: a heterogenous group of neoplasms.
        Am J Surg Pathol. 2016; 40: 989-997
        • Medeiros L.J.
        • Palmedo G.
        • Krigman H.R.
        • et al.
        Oncocytoid renal cell carcinoma after neuroblastoma: a report of four cases of a distinct clinicopathologic entity.
        Am J Surg Pathol. 1999; 23: 772-780
        • Trpkov K.
        • Williamson S.R.
        • Gill A.J.
        • et al.
        Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.
        Mod Pathol. 2021; 34: 1167-1184
        • Amin M.B.
        • McKenney J.K.
        • Martignoni G.
        • et al.
        Low grade oncocytic tumors of the kidney: a clinically relevant approach for the workup and accurate diagnosis.
        Mod Pathol. 2022; 35: 1306-1316
        • Tao J.J.
        • Wei G.
        • Patel R.
        • et al.
        ALK fusions in renal cell carcinoma: response to entrectinib.
        JCO Precis Oncol. 2018; 2: 1-8
        • Shah R.B.
        • Stohr B.A.
        • Tu Z.J.
        • et al.
        "Renal cell carcinoma with leiomyomatous stroma" harbor somatic mutations of TSC1, TSC2, MTOR, and/or ELOC (TCEB1): clinicopathologic and molecular characterization of 18 sporadic tumors supports a distinct entity.
        Am J Surg Pathol. 2020; 44: 571-581
        • Srinivasan R.
        • Su D.
        • Stamatakis L.
        • et al.
        5 Mechanism based targeted therapy for hereditary leiomyomatosis and renal cell cancer (HLRCC) and sporadic papillary renal cell carcinoma: interim results from a phase 2 study of bevacizumab and erlotinib.
        Eur J Cancer. 2014; 50: 8
        • Anglade F.
        • Milner Jr., D.A.
        • Brock J.E.
        Can pathology diagnostic services for cancer be stratified and serve global health?.
        Cancer. 2020; 126: 2431-2438
        • Flocks R.H.
        • Kadesky M.C.
        Malignant neoplasms of the kidney; an analysis of 353 patients followed five years or more.
        J Urol. 1958; 79: 196-201
        • Robson C.J.
        • Churchill B.M.
        • Anderson W.
        The results of radical nephrectomy for renal cell carcinoma.
        J Urol. 1969; 101: 297-301
        • Bonsib S.M.
        • Gibson D.
        • Mhoon M.
        • et al.
        Renal sinus involvement in renal cell carcinomas.
        Am J Surg Pathol. 2000; 24: 451-458
        • Bonsib S.M.
        The renal sinus is the principal invasive pathway: a prospective study of 100 renal cell carcinomas.
        Am J Surg Pathol. 2004; 28: 1594-1600
        • Bonsib S.M.
        T2 clear cell renal cell carcinoma is a rare entity: a study of 120 clear cell renal cell carcinomas.
        J Urol. 2005; 174: 1199-1202
        • Bonsib S.M.
        Renal veins and venous extension in clear cell renal cell carcinoma.
        Mod Pathol. 2007; 20: 44-53
        • Amin M.B.
        • Edge S.
        • Greene F.
        • et al.
        AJCC cancer staging manual.
        8th edition. Springer International Publishing: American Joint Committee on Cancer; Chicago, IL, 2017
        • Paner G.P.
        • Chumbalkar V.
        • Montironi R.
        • et al.
        Updates in grading of renal cell carcinomas beyond clear cell renal cell carcinoma and papillary renal cell carcinoma.
        Adv Anat Pathol. 2022; 29: 117-130
        • Delahunt B.
        • Eble J.N.
        • Egevad L.
        • et al.
        Grading of renal cell carcinoma.
        Histopathology. 2019; 74: 4-17
        • Fuhrman S.A.
        • Lasky L.C.
        • Limas C.
        Prognostic significance of morphologic parameters in renal cell carcinoma.
        Am J Surg Pathol. 1982; 6: 655-663
        • Moch H.H.P.
        • Ulbright T.M.
        • Reuter V.E.
        WHO classification of tumours of the urinary system and male genital organs.
        WHO Classification of Tumours. 4th edition. 8. IARC, Lyon, France2016
        • Ohashi R.
        • Martignoni G.
        • Hartmann A.
        • et al.
        Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading scheme.
        Virchows Arch. 2020; 476: 409-418
        • Volpe A.
        • Novara G.
        • Antonelli A.
        • et al.
        Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
        BJU Int. 2012; 110: 76-83
        • Lopez-Beltran A.
        • Montironi R.
        • Cimadamore A.
        • et al.
        Grading of chromophobe renal cell carcinoma: do we need it?.
        Eur Urol. 2021; 79: 232-233
        • Avulova S.
        • Cheville J.C.
        • Lohse C.M.
        • et al.
        Grading chromophobe renal cell carcinoma: evidence for a four-tiered classification incorporating coagulative tumor necrosis.
        Eur Urol. 2021; 79: 225-231
        • Cheville J.C.
        • Lohse C.M.
        • Sukov W.R.
        • et al.
        Chromophobe renal cell carcinoma: the impact of tumor grade on outcome.
        Am J Surg Pathol. 2012; 36: 851-856
        • Wilcox Vanden Berg R.N.
        • Basourakos S.P.
        • LaRussa S.
        • et al.
        Management of the small renal mass: a 2020 update.
        Curr Oncol Rep. 2020; 22: 69
        • Shen S.S.
        • Ro J.Y.
        Histologic diagnosis of renal mass biopsy.
        Arch Pathol Lab Med. 2019; 143: 705-710
        • Campbell R.A.
        • Scovell J.
        • Rathi N.
        • et al.
        Partial versus radical nephrectomy: complexity of decision-making and utility of AUA guidelines.
        Clin Genitourin Cancer. 2022; 20: 501-509
        • Campbell S.C.
        • Clark P.E.
        • Chang S.S.
        • et al.
        Renal mass and localized renal cancer: evaluation, management, and follow-up: AUA guideline: part I.
        J Urol. 2021; 206: 199-208
        • Campbell S.C.
        • Uzzo R.G.
        • Karam J.A.
        • et al.
        Renal mass and localized renal cancer: evaluation, management, and follow-up: AUA guideline: part II.
        J Urol. 2021; 206: 209-218